Announced Wed, 28 Oct, 2026 · 23:06 IST
Q2 swings to loss as revenue falls; Vayavya Labs acquisition approved
Revenue DeclinePat NegativeEbitda Margin CompressionNegative Operating CashflowResults RestatedResults View source PDFExplain this filing
MOSCHIP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
Q2 consolidated revenue fell 19% to Rs 119.08 crore, with a net loss of Rs 30.40 crore versus profit of Rs 12.04 crore. H1 revenue fell 17% to Rs 235.30 crore, with a Rs 27.96 crore loss and negative operating cash flow of Rs 49.48 crore. Auditors found no material issue. Extra chip costs hurt results; customer reimbursement is under discussion. The board approved buying 73% of Vayavya Labs for Rs 266.71 crore, subject to approvals.
Likely market impact
Weak revenue, profit and cash flow may pressure the stock. The acquisition may add growth but carries integration, funding and share dilution risk.